NutriStack
CautionEmerging evidence
What is happening. Ginkgo has seizure case reports and may undermine antiseizure therapy.
Mechanism. Potential seizure-threshold lowering.
Recommendation. Avoid ginkgo in epilepsy unless approved by the neurologist.
Supplement × Prescription·a caution·Emerging evidence
Ginkgo Biloba + Lacosamide
Caution
Emerging evidence
Ginkgo has seizure case reports and may undermine antiseizure therapy.
From the database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Substances
Pair type
Caution
Evidence
Emerging
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
Stack Score
How it moves the number.
Effect on the composite score
If both Ginkgo Biloba and Lacosamide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
Sources
Sources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Hoy SM. Lacosamide: a review of its use as adjunctive therapy. CNS Drugs. 2013.Needs sourceNo link
Check your full routine
One pair was the worked example.
Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.